Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication-Reference-Cited by-同舟云学术

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

Published:2022-05 Issue:5 Volume:25 Page:104293
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Stegmann Kim M.,Dickmanns Antje,Heinen Natalie,Blaurock Claudia,Karrasch Tim,Breithaupt Angele,Klopfleisch Robert,Uhlig Nadja,Eberlein Valentina,Issmail Leila,Herrmann Simon T.,Schreieck Amelie,Peelen Evelyn,Kohlhof Hella,Sadeghi Balal,Riek Alexander,Speakman John R.,Groß Uwe,Görlich Dirk,Vitt Daniel,Müller Thorsten,Grunwald Thomas,Pfaender Stephanie,Balkema-Buschmann Anne,Dobbelstein Matthias

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference87 articles.

1. Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model;Abdelnabi;J. Infect. Dis.,2021

2. Small-molecule antiviral β-d-N (4)-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance;Agostini;J. Virol.,2019

3. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine;Barnard;Antivir. Chem. Chemother.,2004

4. Remdesivir for the treatment of COVID-19 - final report;Beigel;N. Engl. J. Med.,2020

5. The toxicity of poisons applied jointly;Bliss;Ann. Appl. Biol.,1939

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity;ChemMedChem;2024-08-06

2. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

3. Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry;Nucleosides, Nucleotides & Nucleic Acids;2024-05-13

4. The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19;2024-02-28

5. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication;Antiviral Research;2023-11